Paper28348554
Barriers to Radiation-Induced In Situ Tumor Vaccination.
Wennerberg E and 7 others. Front Immunol, 2017. Cited by 162 papers, by iCite.
Cite this record
ConductScience Library. Barriers to Radiation-Induced In Situ Tumor Vaccination. Papers, record 28348554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28348554
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 CA201246 | NCI NIH HHS | United States | R01CA201246 | PubMed and NIH |
Source NIH RePORTER
References134
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18400190 | Cytokine signaling modules in inflammatory responses. | Immunity | 2008 | https://conductscience.org/library/papers/18400190 | PubMed |
| 2 | 27660705 | Current clinical trials testing the combination of immunotherapy with radiotherapy. | J Immunother Cancer | 2016 | https://conductscience.org/library/papers/27660705 | PubMed |
| 3 | 23316199 | ATP release and purinergic signaling in NLRP3 inflammasome activation. | Front Immunol | 2012 | https://conductscience.org/library/papers/23316199 | PubMed |
| 4 | 19188147 | The macrophage colony-stimulating factor 1 response signature in breast carcinoma. | Clin Cancer Res | 2009 | https://conductscience.org/library/papers/19188147 | PubMed |
| 5 | 22087822 | The role of the adenosinergic pathway in immunosuppression mediated by human regulatory T cells (Treg). | Curr Med Chem | 2011 | https://conductscience.org/library/papers/22087822 | PubMed |
| 6 | 25403716 | Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activity. | Cancer Immunol Res | 2015 | https://conductscience.org/library/papers/25403716 | PubMed |
| 7 | 25377469 | Myeloid expression of adenosine A2A receptor suppresses T and NK cell responses in the solid tumor microenvironment. | Cancer Res | 2014 | https://conductscience.org/library/papers/25377469 | PubMed |
| 8 | 17481928 | T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation. | Immunity | 2007 | https://conductscience.org/library/papers/17481928 | PubMed |
| 9 | 21586363 | Ectonucleotidases as regulators of purinergic signaling in thrombosis, inflammation, and immunity. | Adv Pharmacol | 2011 | https://conductscience.org/library/papers/21586363 | PubMed |
| 10 | 16337366 | Colony-stimulating factor-1 in immunity and inflammation. | Curr Opin Immunol | 2006 | https://conductscience.org/library/papers/16337366 | PubMed |
| 11 | 25481263 | Combination of radiotherapy and immune checkpoint inhibitors. | Semin Radiat Oncol | 2015 | https://conductscience.org/library/papers/25481263 | PubMed |
| 12 | 24336068 | A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells. | Cancer Res | 2014 | https://conductscience.org/library/papers/24336068 | PubMed |
| 13 | 14676299 | Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. | J Exp Med | 2003 | https://conductscience.org/library/papers/14676299 | PubMed |
| 14 | 12465600 | The macrophage growth factor CSF-1 in mammary gland development and tumor progression. | J Mammary Gland Biol Neoplasia | 2002 | https://conductscience.org/library/papers/12465600 | PubMed |
| 15 | 16286245 | TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance. | Cancer Cell | 2005 | https://conductscience.org/library/papers/16286245 | PubMed |
| 16 | 16551245 | Transforming growth factor-beta regulation of immune responses. | Annu Rev Immunol | 2006 | https://conductscience.org/library/papers/16551245 | PubMed |
| 17 | 11390478 | A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood. | J Immunol | 2001 | https://conductscience.org/library/papers/11390478 | PubMed |
| 18 | 24310606 | NT5E and FcGBP as key regulators of TGF-1-induced epithelial-mesenchymal transition (EMT) are associated with tumor progression and survival of patients with gallbladder cancer. | Cell Tissue Res | 2014 | https://conductscience.org/library/papers/24310606 | PubMed |
| 19 | 22287455 | High expression of CD73 as a poor prognostic biomarker in human colorectal cancer. | J Surg Oncol | 2012 | https://conductscience.org/library/papers/22287455 | PubMed |
| 20 | 27209048 | Immunosuppressive activities of adenosine in cancer. | Curr Opin Pharmacol | 2016 | https://conductscience.org/library/papers/27209048 | PubMed |
Cited by118
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 162 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42397620 | Revisiting the Immunological Landscape of Locoregional Therapies for Gastrointestinal Cancers: A Shift Toward Interventional Immuno-Oncology. | Curr Oncol Rep | 2026 | https://conductscience.org/library/papers/42397620 | PubMed |
| 42332706 | Nrf2 deficiency converts the ESCC microenvironment into an immunologically active state via the GPX2-ICD-DC signaling path. | J Transl Med | 2026 | https://conductscience.org/library/papers/42332706 | PubMed |
| 42292397 | Neutrophil extracellular traps in tumor microenvironment for radiotherapy: friend or foe? | Front Immunol | 2026 | https://conductscience.org/library/papers/42292397 | PubMed |
| 42180096 | Complete response of a giant metastatic neck mass in tonsillar squamous cell carcinoma achieved with radiotherapy combined with immunotherapy: a case report. | Front Oncol | 2026 | https://conductscience.org/library/papers/42180096 | PubMed |
| 41988184 | Iodine-125 brachytherapy triggers immunogenic cell death and potentiates anti-PD-L1 immunotherapy in bone metastatic triple-negative breast cancer. | Front Immunol | 2026 | https://conductscience.org/library/papers/41988184 | PubMed |
| 40900811 | Cancer Immunotherapy in Combination with Radiotherapy and/or Chemotherapy: Mechanisms and Clinical Therapy. | MedComm (2020) | 2025 | https://conductscience.org/library/papers/40900811 | PubMed |
| 40861450 | Synergies between radiotherapy and immunotherapy: a systematic review from mechanism to clinical application. | Front Immunol | 2025 | https://conductscience.org/library/papers/40861450 | PubMed |
| 40707495 | The untapped potential of radiation and immunotherapy for hormone receptor-positive breast cancer. | NPJ Breast Cancer | 2025 | https://conductscience.org/library/papers/40707495 | PubMed |
| 40583465 | Anti-Tumor Immunization Efficacy after Particle-Radiation Exposure. | Radiat Res | 2025 | https://conductscience.org/library/papers/40583465 | PubMed |
| 40453074 | Interplay between cancer-associated fibroblasts and dendritic cells: implications for tumor immunity. | Front Immunol | 2025 | https://conductscience.org/library/papers/40453074 | PubMed |
| 40438865 | Combination of radiotherapy and ICIs in advanced hepatocellular carcinoma: A systematic review of current evidence and future prospects (Review). | Oncol Lett | 2025 | https://conductscience.org/library/papers/40438865 | PubMed |
| 40405246 | Carbon ion irradiation mobilizes antitumor immunity: from concept to the clinic. | Radiat Oncol | 2025 | https://conductscience.org/library/papers/40405246 | PubMed |
| 40247328 | Nanomaterials-driven in situ vaccination: a novel frontier in tumor immunotherapy. | J Hematol Oncol | 2025 | https://conductscience.org/library/papers/40247328 | PubMed |
| 40236706 | Radical hemithorax radiotherapy induces an increase in circulating PD-1+ T lymphocytes and in the soluble levels of PD-L1 in malignant pleural mesothelioma patients: a possible synergy with PD-1/PD-L1 targeting treatment? | Front Immunol | 2025 | https://conductscience.org/library/papers/40236706 | PubMed |
| 40223683 | In Situ Cancer Vaccines: Redefining Immune Activation in the Tumor Microenvironment. | ACS Biomater Sci Eng | 2025 | https://conductscience.org/library/papers/40223683 | PubMed |
| 39872847 | CD73/adenosine dynamics in treatment-induced pneumonitis: balancing efficacy with risks of adverse events in combined radio-immunotherapies. | Front Cell Dev Biol | 2024 | https://conductscience.org/library/papers/39872847 | PubMed |
| 39308864 | Immunological signatures from irradiated cancer-associated fibroblasts. | Front Immunol | 2024 | https://conductscience.org/library/papers/39308864 | PubMed |
| 38853541 | Role of HIF-1α in the Responses of Tumors to Radiotherapy and Chemotherapy. | Cancer Res Treat | 2025 | https://conductscience.org/library/papers/38853541 | PubMed |
| 38773258 | Combination of proton- or X-irradiation with anti-PDL1 immunotherapy in two murine oral cancers. | Sci Rep | 2024 | https://conductscience.org/library/papers/38773258 | PubMed |
| 38488488 | Radiation-induced effects on TGF-β and PDGF receptor signaling in cancer-associated fibroblasts. | Cancer Rep (Hoboken) | 2024 | https://conductscience.org/library/papers/38488488 | PubMed |
Genes27
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28348554
GET https://conductscience.org/api/papers/v1/28348554/references?page=2